Shengguang Zhao

Featured in: Favicon

biomedcentral.com Favicon

futuremedicine.com Favicon

ejcancer.com Favicon

bmccancer.biomedcentral.com

Articles

The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort | BMC Cancer | Full Text

Aug 20, 2024 | bmccancer.biomedcentral.com | Wei-xiang Qi |Shuyan Li |Huan Li |Jiayi Chen |Shengguang Zhao

The study was designed as a prospective cohort from four prospective trials (NCT NCT04435197, NCT04435197, NCT04513418, NCT03990532) [24,25,26], and all included patients were treated with NCRT with or without pembrolizumab followed by esophagectomy and reconstructed the conduit with a narrow gastric tube intrathoracic or cervical anastomosis at Ruijin Hospital, Shanghai Jiao Tong university school of medicine, between Jan 2019 and July 2023.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →